Cj. Lockwood et al., The role of tissue factor in regulating endometrial haemostasis: implications for progestin-only contraception, HUM REPR, 15, 2000, pp. 144-151
Abnormal uterine bleeding accounts for the unacceptably high discontinuatio
n rate of progestin-only contraceptives. Previously, we found that in-vivo
and in-vitro decidualization of human endometrial stromal cells was associa
ted with elevated concentrations of tissue factor (TF), the primary initiat
or of haemostasis, Moreover, enhanced TF expression required progesterone r
eceptor (PR) and epidermal growth factor receptor (EGFR) mediation. In the
current study, endometrial biopsies were sampled from bleeding (BL) and non
-bleeding (NBL) sites under camera-directed hysteroscopic guidance after De
po-provera injections. When compared with control biopsies, immunohistochem
ical examination revealed that 3 months of Depo-provera contraception reduc
ed TF concentrations at the BL sites. However, there were ample EGFR and PR
concentrations at BL and NBL sites. Moreover, there was a trend towards th
e appearance of pathologically enlarged blood vessels at the BL sites, The
use of Western blotting revealed that after 3 months of Depo-provera, conce
ntrations of both PRE and PRA isoforms were lower at BL versus NBL sites wi
th decreased PRA concentrations attaining statistical significance. Separat
e sampling of endometrial BL and NBL sites as shown here for Depo-provera c
ontraception could prove particularly useful in identifying local factors t
hat determine the onset of bleeding during the more protracted time-course
of Norplant(R) contraception.